Medtronic has announced the CE Mark in Europe and the start of us ide first cases for the Sphere-360 PFA catheter, which is used to treat paroxysmal atrial fibrillation. The company has also reported milestones in clinical studies for its catheters, including the Sphere-9 and Sphere-360. Additionally, Medtronic has recently reported its full year and fourth quarter fiscal results, although it is unclear if the announcements are directly related to its financial performance.